BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 7689695)

  • 1. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I.
    Aronica SM; Katzenellenbogen BS
    Mol Endocrinol; 1993 Jun; 7(6):743-52. PubMed ID: 7689695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3',5'-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors.
    Aronica SM; Katzenellenbogen BS
    Endocrinology; 1991 Apr; 128(4):2045-52. PubMed ID: 1706263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
    Cho H; Katzenellenbogen BS
    Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectivity and promoter dependence.
    Fujimoto N; Katzenellenbogen BS
    Mol Endocrinol; 1994 Mar; 8(3):296-304. PubMed ID: 7517003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3',5'-monophosphate, estradiol, insulin-like growth factor-I, and serum factors.
    Cho H; Aronica SM; Katzenellenbogen BS
    Endocrinology; 1994 Feb; 134(2):658-64. PubMed ID: 7507831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3',5'-monophosphate and ligands including antiestrogens.
    Ince BA; Montano MM; Katzenellenbogen BS
    Mol Endocrinol; 1994 Oct; 8(10):1397-406. PubMed ID: 7531820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-independent activation of steroid receptors.
    Flint AP; Sheldrick EL; Fisher PA
    Domest Anim Endocrinol; 2002 Jul; 23(1-2):13-24. PubMed ID: 12142222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen responses in bovine fetal uterine cells involve pathways directed by both estrogen response element and activator protein-1.
    Malayer JR; Cheng J; Woods VM
    Biol Reprod; 1999 May; 60(5):1204-10. PubMed ID: 10208985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol.
    Ignar-Trowbridge DM; Pimentel M; Parker MG; McLachlan JA; Korach KS
    Endocrinology; 1996 May; 137(5):1735-44. PubMed ID: 8612509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
    Chalbos D; Philips A; Galtier F; Rochefort H
    Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor, cyclic adenosine monophosphate, and protein kinase A are involved in the nongenomic pathway by which estradiol accelerates oviductal oocyte transport in cyclic rats.
    Orihuela PA; Parada-Bustamante A; Cortés PP; Gatica C; Croxatto HB
    Biol Reprod; 2003 Apr; 68(4):1225-31. PubMed ID: 12606351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of insulin-like growth factor-I in regulating estrogen receptor-alpha gene expression.
    Stoica A; Saceda M; Fakhro A; Joyner M; Martin MB
    J Cell Biochem; 2000 Jan; 76(4):605-14. PubMed ID: 10653980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogens modulate the responsiveness of osteoblast-like cells (ROS 17/2.8) stably transfected with estrogen receptor.
    Migliaccio S; Davis VL; Gibson MK; Gray TK; Korach KS
    Endocrinology; 1992 May; 130(5):2617-24. PubMed ID: 1572285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of growth factors on estrogen receptor mediated gene expression.
    Hafner F; Holler E; von Angerer E
    J Steroid Biochem Mol Biol; 1996 Jul; 58(4):385-93. PubMed ID: 8903422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells.
    Hurd C; Dinda S; Khattree N; Moudgil VK
    Oncogene; 1999 Jan; 18(4):1067-72. PubMed ID: 10023683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning of the rat progesterone receptor gene 5'-region and identification of two functionally distinct promoters.
    Kraus WL; Montano MM; Katzenellenbogen BS
    Mol Endocrinol; 1993 Dec; 7(12):1603-16. PubMed ID: 8145766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk.
    Klotz DM; Hewitt SC; Ciana P; Raviscioni M; Lindzey JK; Foley J; Maggi A; DiAugustine RP; Korach KS
    J Biol Chem; 2002 Mar; 277(10):8531-7. PubMed ID: 11751931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of blockers for the estrogen receptor (ER) and type 1 IGF-receptor on the levels of ER, ER mRNA and IGF-I mRNA in the rat uterus.
    Sahlin L; Eriksson H
    J Steroid Biochem Mol Biol; 1996 Jul; 58(4):359-65. PubMed ID: 8903419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
    Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
    Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of estrogen receptor in HTB 96 human osteosarcoma cells results in estrogen-induced growth inhibition and receptor cross talk.
    Watts CK; King RJ
    J Bone Miner Res; 1994 Aug; 9(8):1251-8. PubMed ID: 7976507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.